BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19785507)

  • 1. Recent patent trends in the field of progesterone receptor agonists and modulators.
    Schmees N; Weinmann H
    Expert Opin Ther Pat; 2009 Nov; 19(11):1521-34. PubMed ID: 19785507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal progesterone receptor modulators: structure activity relationships.
    Winneker RC; Fensome A; Wrobel JE; Zhang Z; Zhang P
    Semin Reprod Med; 2005 Feb; 23(1):46-57. PubMed ID: 15714389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery, chemistry, and reproductive pharmacology of asoprisnil and related 11beta-benzaldoxime substituted selective progesterone receptor modulators (SPRMs).
    Schubert G; Elger W; Kaufmann G; Schneider B; Reddersen G; Chwalisz K
    Semin Reprod Med; 2005 Feb; 23(1):58-73. PubMed ID: 15714390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone receptor antagonists and selective progesterone receptor modulators (SPRMs).
    Spitz IM
    Semin Reprod Med; 2005 Feb; 23(1):3-7. PubMed ID: 15714385
    [No Abstract]   [Full Text] [Related]  

  • 5. Contraceptives with novel benefits.
    Su Y; Lian QQ; Ge RS
    Expert Opin Investig Drugs; 2012 Jan; 21(1):83-90. PubMed ID: 22149760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety.
    Bouchard P; Chabbert-Buffet N; Fauser BC
    Fertil Steril; 2011 Nov; 96(5):1175-89. PubMed ID: 21944187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigational hormone receptor agonists as ongoing female contraception: a focus on selective progesterone receptor modulators in early clinical development.
    Nelson AL
    Expert Opin Investig Drugs; 2015; 24(10):1321-30. PubMed ID: 26289789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs).
    Wardell SE; Edwards DP
    Semin Reprod Med; 2005 Feb; 23(1):9-21. PubMed ID: 15714386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel progesterone receptor modulators with gene selective and context-dependent partial agonism.
    Berrodin TJ; Jelinsky SA; Graciani N; Butera JA; Zhang Z; Nagpal S; Winneker RC; Yudt MR
    Biochem Pharmacol; 2009 Jan; 77(2):204-15. PubMed ID: 19013437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators.
    Pintiaux A; Chabbert-Buffet N; Foidart JM
    Gynecol Endocrinol; 2009 Feb; 25(2):67-73. PubMed ID: 19253100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the development of selective androgen receptor modulators.
    Zhang X; Lanter JC; Sui Z
    Expert Opin Ther Pat; 2009 Sep; 19(9):1239-58. PubMed ID: 19505196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone receptor antagonists and the endometrial antiproliferative effect.
    Brenner RM; Slayden OD
    Semin Reprod Med; 2005 Feb; 23(1):74-81. PubMed ID: 15714391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new generation of progesterone receptor modulators.
    Winneker RC; Fensome A; Zhang P; Yudt MR; McComas CC; Unwalla RJ
    Steroids; 2008 Aug; 73(7):689-701. PubMed ID: 18472121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis.
    Chwalisz K; Perez MC; Demanno D; Winkel C; Schubert G; Elger W
    Endocr Rev; 2005 May; 26(3):423-38. PubMed ID: 15857972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications.
    Rodriguez MI; Warden M; Darney PD
    Am J Obstet Gynecol; 2010 May; 202(5):420-8. PubMed ID: 20031112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selective progesterone receptor modulators: future clinical applications].
    Bouchard P; Ouzounian S; Chabbert-Buffet N
    Bull Acad Natl Med; 2008; 192(6):1159-71; discussion 1172-3. PubMed ID: 19235480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Progresses and Trends in the Development of Progesterone Receptor Modulators.
    Li W; Li X; Zhang B; Gao C; Chen Y; Jiang Y
    Curr Med Chem; 2016; 23(23):2507-54. PubMed ID: 27121188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications.
    Chabbert-Buffet N; Meduri G; Bouchard P; Spitz IM
    Hum Reprod Update; 2005; 11(3):293-307. PubMed ID: 15790602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11-(pyridinylphenyl)steroids--a new class of mixed-profile progesterone agonists/antagonists.
    Rewinkel J; Enthoven M; Golstein I; van der Rijst M; Scholten A; van Tilborg M; de Weys D; Wisse J; Hamersma H
    Bioorg Med Chem; 2008 Mar; 16(6):2753-63. PubMed ID: 18243712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selective progesterone receptor modulators and their therapeutical use].
    Driák D; Sehnal B; Svandová I
    Ceska Gynekol; 2013 Apr; 78(2):175-81. PubMed ID: 23710982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.